Compare Quest Diagnostics Inc (DGX) vs YieldMax NVDA Option Income Strategy ETF (NVDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while YieldMax NVDA Option Income Strategy ETF trades at $12.57 (market cap $1.45B). The key difference: Quest Diagnostics Inc is far larger — about 17.6× YieldMax NVDA Option Income Strategy ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while YieldMax NVDA Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| DGX | NVDY | |
|---|---|---|
Market Cap | $25.48B | $1.45B |
Volume | 941,866 | 1,943,739 |
Sector | Health | Income / Options Overlay |
52-Week High | $247.45 | $17.21 |
52-Week Low | $173.49 | $11.58 |
Typical Hold Time | 56 Days | 43 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.
DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.
NVDY, the YieldMax NVDA Option Income Strategy ETF, trades at $12.62, down 3.0% today, amid a bearish technical signal. The fund generates income via options on NVIDIA stock, with recent weekly dividends averaging around $0.10. However, technical indicators show selling pressure, with moving averages and ADX signaling bearish momentum, while oscillators remain neutral. Recent news highlights concerns over NAV erosion and capped upside despite high distribution yields.
The outlook is cautious due to structural limitations on capital appreciation and reliance on NVIDIA's volatility for income. Risks include potential NAV decay from the options strategy and sensitivity to changes in implied volatility. Analyst sentiment is neutral to bearish, with downgrades citing diminished income potential. Investors seeking NVIDIA exposure may find direct ownership more favorable for growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →
